Birdwatch Note
2024-11-02 06:54:39 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
「歴史は繰り返している」はコスタイベ(レプリコンワクチン)のことを指すと思われます https://www.sankei.com/article/20241028-A2VBLDDO3JMJJKIAAR2KRTXAR4/ https://www.tokyo-np.co.jp/article/363137 https://mainichi.jp/articles/20241101/k00/00m/040/266000c 水俣病の公式確認の3年後の1959年11月12日厚生省食品衛生調査会答申では「主因をなすものはある種の有機水銀化合物」と答申され、その前年9月の排水場所変更によって被害地域が変わるという因果関係を示唆する根拠がありました https://www.env.go.jp/chemi/tmms/pr-m/mat01/ja_full.pdf 企業が非協力的だったことは事実ですが、厚生省(当時)が工場廃液原因説を否定した事実は確認できません https://www.env.go.jp/council/26minamata/y260-05/mat02.pdf 一方、コスタイベは治験で安全性と有効性は確認して厚労省が承認しました https://doi.org/10.1038/s41467-024-47905-1 https://www.mhlw.go.jp/content/10906000/001316061.pdf https://www.pmda.go.jp/drugs/2024/P20240917001/780009000_30500AMX00282_A100_1.pdf https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/vaccine_qa.html#20 根拠の有無や厚労省の対応等が全く違います
Written by EE7192EF0B1C47D8A3430C3E070DA2A0BFAA58717F9133404318E9D7666B1A00
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1852528718033650133
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1852605221857583373
- noteId - 1852605221857583373
- participantId -
- noteAuthorParticipantId - EE7192EF0B1C47D8A3430C3E070DA2A0BFAA58717F9133404318E9D7666B1A00 Participant Details
- createdAtMillis - 1730530479288
- tweetId - 1852528718033650133
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 「歴史は繰り返している」はコスタイベ(レプリコンワクチン)のことを指すと思われます https://www.sankei.com/article/20241028-A2VBLDDO3JMJJKIAAR2KRTXAR4/ https://www.tokyo-np.co.jp/article/363137 https://mainichi.jp/articles/20241101/k00/00m/040/266000c 水俣病の公式確認の3年後の1959年11月12日厚生省食品衛生調査会答申では「主因をなすものはある種の有機水銀化合物」と答申され、その前年9月の排水場所変更によって被害地域が変わるという因果関係を示唆する根拠がありました https://www.env.go.jp/chemi/tmms/pr-m/mat01/ja_full.pdf 企業が非協力的だったことは事実ですが、厚生省(当時)が工場廃液原因説を否定した事実は確認できません https://www.env.go.jp/council/26minamata/y260-05/mat02.pdf 一方、コスタイベは治験で安全性と有効性は確認して厚労省が承認しました https://doi.org/10.1038/s41467-024-47905-1 https://www.mhlw.go.jp/content/10906000/001316061.pdf https://www.pmda.go.jp/drugs/2024/P20240917001/780009000_30500AMX00282_A100_1.pdf https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/vaccine_qa.html#20 根拠の有無や厚労省の対応等が全く違います
Note Ratings
rated at | rated by | |
2024-11-02 10:53:36 -0500 | Rating Details | |
2024-11-02 10:05:45 -0500 | Rating Details | |
2024-11-02 09:20:36 -0500 | Rating Details | |
2024-11-02 08:15:47 -0500 | Rating Details | |
2024-11-02 06:07:06 -0500 | Rating Details | |
2024-11-02 05:09:00 -0500 | Rating Details | |
2024-11-02 03:31:15 -0500 | Rating Details | |
2024-11-02 03:28:13 -0500 | Rating Details | |
2024-11-02 02:58:53 -0500 | Rating Details | |
2024-11-02 02:50:41 -0500 | Rating Details | |
2024-11-02 02:39:11 -0500 | Rating Details | |
2024-11-02 02:28:28 -0500 | Rating Details | |
2024-11-02 02:02:04 -0500 | Rating Details | |
2024-11-04 05:17:00 -0600 | Rating Details | |
2024-11-03 04:27:44 -0600 | Rating Details | |
2024-11-03 00:17:23 -0500 | Rating Details | |
2024-11-02 23:34:31 -0500 | Rating Details | |
2024-11-02 23:24:40 -0500 | Rating Details | |
2024-11-02 23:21:45 -0500 | Rating Details | |
2024-11-02 22:00:55 -0500 | Rating Details | |
2024-11-02 21:27:37 -0500 | Rating Details | |
2024-11-02 20:16:05 -0500 | Rating Details | |
2024-11-02 19:43:14 -0500 | Rating Details | |
2024-11-02 19:00:56 -0500 | Rating Details | |
2024-11-02 17:58:36 -0500 | Rating Details | |
2024-11-02 15:36:53 -0500 | Rating Details | |
2024-11-02 06:23:23 -0500 | Rating Details | |
2024-11-02 05:46:06 -0500 | Rating Details | |
2024-11-02 05:16:51 -0500 | Rating Details | |
2024-11-02 05:08:27 -0500 | Rating Details | |
2024-11-02 04:24:17 -0500 | Rating Details | |
2024-11-02 04:18:53 -0500 | Rating Details | |
2024-11-02 03:13:06 -0500 | Rating Details | |
2024-11-02 03:04:11 -0500 | Rating Details | |
2024-11-02 02:56:00 -0500 | Rating Details | |
2024-11-02 02:46:19 -0500 | Rating Details | |
2024-11-02 02:43:23 -0500 | Rating Details | |
2024-11-02 02:34:18 -0500 | Rating Details | |
2024-11-02 02:14:11 -0500 | Rating Details | |
2024-11-02 02:02:14 -0500 | Rating Details | |
2024-11-03 06:56:33 -0600 | Rating Details | |
2024-11-03 05:06:13 -0600 | Rating Details | |
2024-11-03 04:15:11 -0600 | Rating Details | |
2024-11-03 01:18:49 -0600 | Rating Details | |
2024-11-02 19:53:15 -0500 | Rating Details | |
2024-11-02 06:57:48 -0500 | Rating Details | |
2024-11-02 04:50:29 -0500 | Rating Details | |
2024-11-02 04:34:48 -0500 | Rating Details | |
2024-11-02 04:29:54 -0500 | Rating Details | |
2024-11-02 04:27:09 -0500 | Rating Details | |
2024-11-02 02:41:27 -0500 | Rating Details | |
2024-11-02 02:39:33 -0500 | Rating Details | |
2024-11-02 02:18:33 -0500 | Rating Details | |
2024-11-02 02:16:23 -0500 | Rating Details | |
2024-11-02 02:11:03 -0500 | Rating Details | |
2024-11-02 02:07:15 -0500 | Rating Details | |
2024-11-02 02:02:42 -0500 | Rating Details | |
2024-11-03 10:46:41 -0600 | Rating Details | |
2024-11-03 07:55:02 -0600 | Rating Details | |
2024-11-03 07:18:28 -0600 | Rating Details | |
2024-11-03 05:13:18 -0600 | Rating Details | |
2024-11-02 23:34:07 -0500 | Rating Details | |
2024-11-02 19:49:44 -0500 | Rating Details | |
2024-11-02 16:57:51 -0500 | Rating Details | |
2024-11-02 11:32:47 -0500 | Rating Details | |
2024-11-02 05:49:31 -0500 | Rating Details | |
2024-11-02 05:39:43 -0500 | Rating Details | |
2024-11-02 05:27:40 -0500 | Rating Details | |
2024-11-02 05:02:37 -0500 | Rating Details | |
2024-11-02 03:42:37 -0500 | Rating Details | |
2024-11-02 03:39:25 -0500 | Rating Details | |
2024-11-02 03:37:30 -0500 | Rating Details | |
2024-11-02 03:17:47 -0500 | Rating Details | |
2024-11-02 03:11:14 -0500 | Rating Details | |
2024-11-02 03:01:42 -0500 | Rating Details | |
2024-11-02 02:56:42 -0500 | Rating Details | |
2024-11-02 02:40:10 -0500 | Rating Details | |
2024-11-02 02:35:12 -0500 | Rating Details | |
2024-11-02 02:30:27 -0500 | Rating Details | |
2024-11-02 02:04:15 -0500 | Rating Details | |
2024-11-03 23:32:01 -0600 | Rating Details | |
2024-11-03 16:54:41 -0600 | Rating Details | |
2024-11-03 00:49:12 -0500 | Rating Details | |
2024-11-02 23:10:15 -0500 | Rating Details | |
2024-11-02 21:24:42 -0500 | Rating Details | |
2024-11-02 14:18:31 -0500 | Rating Details | |
2024-11-02 14:00:19 -0500 | Rating Details | |
2024-11-02 13:39:59 -0500 | Rating Details | |
2024-11-02 06:40:31 -0500 | Rating Details | |
2024-11-02 06:36:28 -0500 | Rating Details | |
2024-11-02 06:07:06 -0500 | Rating Details | |
2024-11-02 06:04:01 -0500 | Rating Details | |
2024-11-02 05:52:48 -0500 | Rating Details | |
2024-11-02 05:46:14 -0500 | Rating Details | |
2024-11-02 05:24:47 -0500 | Rating Details | |
2024-11-02 04:05:23 -0500 | Rating Details | |
2024-11-02 03:04:31 -0500 | Rating Details | |
2024-11-02 02:56:59 -0500 | Rating Details | |
2024-11-02 02:51:42 -0500 | Rating Details | |
2024-11-02 02:42:16 -0500 | Rating Details | |
2024-11-02 02:42:06 -0500 | Rating Details | |
2024-11-02 02:16:18 -0500 | Rating Details | |
2024-11-02 02:07:53 -0500 | Rating Details |